Search - tctmd.com

Displaying 61 - 80 of 216

Sort: Relevancy | Date

Presentation TCT 2019

STOPDAPT, SMART-CHOICE, and TWILIGHT: Will These Trials Change Your Clinical Practice?

Presenter: Aditya Kapoor

September 28, 2019

Presentation TCT 2019

STOPDAPT-2 HBR: 1-Year Outcomes From a Randomized Trial of Clopidogrel Monotherapy vs. DAPT Beginning 1 Month After PCI in Patients at High Bleeding Risk

Presenter: Hirotoshi Watanabe

September 28, 2019

Presentation TCT 2019

AUGUSTUS: Hospitalizations From a 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation

Presenter: Amit Vora

September 28, 2019

Presentation TCT 2019

Aspirin Variability, Interactions and Impact of Different Formulations

Presenter: Dominick Angiolillo

September 28, 2019

Presentation TCT 2019

Evidence for Chronic Aspirin Use in CV Patients: COMPASS and More

Presenter: Sanjit Jolly

September 28, 2019

Presentation TCT 2019

Aspirin Use for Primary and Secondary Prevention: Critical Appraisal of What We Know and What We Don't

Presenter: Davide Capodanno

September 28, 2019

Presentation TCT 2019

Case #2 Introduction: Intravenous Platelet Inhibition During PCI in Complex Stable CAD

Presenter: Francesco Franchi

September 27, 2019

Presentation TCT 2019

DISRUPT CAD II: A Single-Arm Study of Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses

Presenter: Carlo Di Mario

September 27, 2019

Presentation TCT 2019

GLOBAL LEADERS: Ticagrelor Monotherapy vs. DAPT After PCI in TWILIGHT-Like Patients

Presenter: Yoshinobu Onuma

September 27, 2019

Presentation TCT 2019

LM PCI: One Year of DAPT Is Enough, and Sometimes Even Less Is More!

Presenter: Davide Capodanno

September 27, 2019

Presentation TCT 2019

LM PCI: The Default Is Prolonged DAPT (>1 year)!

Presenter: Robert Yeh

September 27, 2019

Presentation TCT 2019

Clinical Insights: The Evidence and Technique Behind Orbital Atherectomy

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

New Insights on Orbital Technology

Presenter: Jeffrey Chambers

September 27, 2019

Presentation TCT 2019

Taking Control: Treatment Planning in Complex PCI

Presenter: Sandeep Nathan

September 27, 2019

Presentation TCT 2019

Japan's Interventional Practice: Japan's Experience With Imaging in the Complex PCI Patient Population

Presenter: takashi ashikaga

September 27, 2019

Presentation TCT 2019

The Changing Interventional Practice: Managing a Complex PCI Patient Population

Presenter: Richard Shlofmitz

September 27, 2019

Presentation TCT 2019

Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated?

Presenter: Davide Capodanno

September 27, 2019

Presentation TCT 2019

Case 2: How Microcirculatory Function Testing Changed My Management in a Patient Without Significant CAD

Presenter: Bruce Samuels

September 26, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

Advertisement

STOPDAPT, SMART-CHOICE, and TWILIGHT: Will These Trials Change Your Clinical Practice?

STOPDAPT-2 HBR: 1-Year Outcomes From a Randomized Trial of Clopidogrel Monotherapy vs. DAPT Beginning 1 Month After PCI in Patients at High Bleeding Risk

AUGUSTUS: Hospitalizations From a 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation

Aspirin Variability, Interactions and Impact of Different Formulations

Evidence for Chronic Aspirin Use in CV Patients: COMPASS and More

Aspirin Use for Primary and Secondary Prevention: Critical Appraisal of What We Know and What We Don't

Case #2 Introduction: Intravenous Platelet Inhibition During PCI in Complex Stable CAD

DISRUPT CAD II: A Single-Arm Study of Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses

GLOBAL LEADERS: Ticagrelor Monotherapy vs. DAPT After PCI in TWILIGHT-Like Patients

LM PCI: One Year of DAPT Is Enough, and Sometimes Even Less Is More!

LM PCI: The Default Is Prolonged DAPT (>1 year)!

Clinical Insights: The Evidence and Technique Behind Orbital Atherectomy

New Insights on Orbital Technology

Taking Control: Treatment Planning in Complex PCI

Japan's Interventional Practice: Japan's Experience With Imaging in the Complex PCI Patient Population

The Changing Interventional Practice: Managing a Complex PCI Patient Population

Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated?

Case 2: How Microcirculatory Function Testing Changed My Management in a Patient Without Significant CAD

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content